TY - JOUR AU - Freudenberg, J. A. AU - Wang, Q. AU - Katsumata, M. AU - Drebin, J. AU - Nagatomo, I. AU - Greene, M. I. PY - 2009 DA - 2009// TI - The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies JO - Exp Mol Pathol VL - 87 UR - https://doi.org/10.1016/j.yexmp.2009.05.001 DO - 10.1016/j.yexmp.2009.05.001 ID - Freudenberg2009 ER - TY - JOUR AU - Roses, R. E. AU - Paulson, E. C. AU - Sharma, A. AU - Schueller, J. E. AU - Nisenbaum, H. AU - Weinstein, S. AU - Fox, K. R. AU - Zhang, P. J. AU - Czerniecki, B. J. PY - 2009 DA - 2009// TI - HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer JO - Cancer Epidemiol Biomarkers Prev VL - 18 UR - https://doi.org/10.1158/1055-9965.EPI-08-1101 DO - 10.1158/1055-9965.EPI-08-1101 ID - Roses2009 ER - TY - JOUR AU - Xu, F. J. AU - Stack, S. AU - Boyer, C. AU - O'Briant, K. AU - Whitaker, R. AU - Mills, G. B. AU - Yu, Y. H. AU - Bast, R. C. PY - 1997 DA - 1997// TI - Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis JO - Clin Cancer Res VL - 3 ID - Xu1997 ER - TY - JOUR AU - Tovey, S. M. AU - Brown, S. AU - Doughty, J. C. AU - Mallon, E. A. AU - Cooke, T. G. AU - Edwards, J. PY - 2009 DA - 2009// TI - Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604940 DO - 10.1038/sj.bjc.6604940 ID - Tovey2009 ER - TY - JOUR AU - De Placido, S. AU - Carlomagno, C. AU - De Laurentiis, M. AU - Bianco, A. R. PY - 1998 DA - 1998// TI - c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients JO - Breast Cancer Res Treat VL - 52 UR - https://doi.org/10.1023/A:1006159001039 DO - 10.1023/A:1006159001039 ID - De Placido1998 ER - TY - JOUR AU - Henderson, I. C. AU - Patek, A. J. PY - 1998 DA - 1998// TI - The relationship between prognostic and predictive factors in the management of breast cancer JO - Breast Cancer Res Treat VL - 52 UR - https://doi.org/10.1023/A:1006141703224 DO - 10.1023/A:1006141703224 ID - Henderson1998 ER - TY - JOUR AU - Meng, S. AU - Tripathy, D. AU - Shete, S. AU - Ashfaq, R. AU - Haley, B. AU - Perkins, S. AU - Beitsch, P. AU - Khan, A. AU - Euhus, D. AU - Osborne, C. PY - 2004 DA - 2004// TI - HER-2 gene amplification can be acquired as breast cancer progresses JO - Proc Natl Acad Sci USA VL - 101 UR - https://doi.org/10.1073/pnas.0402993101 DO - 10.1073/pnas.0402993101 ID - Meng2004 ER - TY - JOUR AU - Tsutsui, S. AU - Ohno, S. AU - Murakami, S. AU - Kataoka, A. AU - Kinoshita, J. AU - Hachitanda, Y. PY - 2002 DA - 2002// TI - Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancer JO - Breast Cancer VL - 9 UR - https://doi.org/10.1007/BF02967575 DO - 10.1007/BF02967575 ID - Tsutsui2002 ER - TY - JOUR AU - Simon, R. AU - Nocito, A. AU - Hubscher, T. AU - Bucher, C. AU - Torhorst, J. AU - Schraml, P. AU - Bubendorf, L. AU - Mihatsch, M. M. AU - Moch, H. AU - Wilber, K. PY - 2001 DA - 2001// TI - Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer JO - J Natl Cancer Inst VL - 93 UR - https://doi.org/10.1093/jnci/93.15.1141 DO - 10.1093/jnci/93.15.1141 ID - Simon2001 ER - TY - JOUR AU - Molina, M. A. AU - Saez, R. AU - Ramsey, E. E. AU - Garcia-Barchino, M. J. AU - Rojo, F. AU - Evans, A. J. AU - Albanell, J. AU - Keenan, E. J. AU - Lluch, A. AU - Garcia-Conde, J. PY - 2002 DA - 2002// TI - NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancer JO - Clin Cancer Res VL - 8 ID - Molina2002 ER - TY - JOUR AU - Lennon, S. AU - Barton, C. AU - Banken, L. AU - Gianni, L. AU - Marty, M. AU - Baselga, J. AU - Leyland-Jones, B. PY - 2009 DA - 2009// TI - Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.16.8351 DO - 10.1200/JCO.2008.16.8351 ID - Lennon2009 ER - TY - JOUR AU - Leary, A. F. AU - Hanna, W. M. AU - van de Vijver, M. J. AU - Penault-Llorca, F. AU - Ruschoff, J. AU - Osamura, R. Y. AU - Bilous, M. AU - Dowsett, M. PY - 2009 DA - 2009// TI - Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.3989 DO - 10.1200/JCO.2008.17.3989 ID - Leary2009 ER - TY - JOUR AU - Harris, L. AU - Fritsche, H. AU - Mennel, R. AU - Norton, L. AU - Ravdin, P. AU - Taube, S. AU - Somerfield, M. R. AU - Hayes, D. F. AU - Bast, R. C. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.14.2364 DO - 10.1200/JCO.2007.14.2364 ID - Harris2007 ER - TY - JOUR AU - Page-McCaw, A. AU - Ewald, A. J. AU - Werb, Z. PY - 2007 DA - 2007// TI - Matrix metalloproteinases and the regulation of tissue remodelling JO - Nat Rev Mol Cell Biol VL - 8 UR - https://doi.org/10.1038/nrm2125 DO - 10.1038/nrm2125 ID - Page-McCaw2007 ER - TY - JOUR AU - Talvensaari-Mattila, A. AU - Paakko, P. AU - Turpeenniemi-Hujanen, T. PY - 2003 DA - 2003// TI - Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma JO - Br J Cancer VL - 89 UR - https://doi.org/10.1038/sj.bjc.6601238 DO - 10.1038/sj.bjc.6601238 ID - Talvensaari-Mattila2003 ER - TY - JOUR AU - Pellikainen, J. M. AU - Ropponen, K. M. AU - Kataja, V. V. AU - Kellokoski, J. K. AU - Eskelinen, M. J. AU - Kosma, V. M. PY - 2004 DA - 2004// TI - Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-1061 DO - 10.1158/1078-0432.CCR-04-1061 ID - Pellikainen2004 ER - TY - JOUR AU - Murphy, G. PY - 2008 DA - 2008// TI - The ADAMs: signalling scissors in the tumour microenvironment JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2459 DO - 10.1038/nrc2459 ID - Murphy2008 ER - TY - JOUR AU - Deryugina, E. I. AU - Quigley, J. P. PY - 2006 DA - 2006// TI - Matrix metalloproteinases and tumor metastasis JO - Cancer Metastasis Rev VL - 25 UR - https://doi.org/10.1007/s10555-006-7886-9 DO - 10.1007/s10555-006-7886-9 ID - Deryugina2006 ER - TY - JOUR AU - Liu, P. C. AU - Liu, X. AU - Li, Y. AU - Covington, M. AU - Wynn, R. AU - Huber, R. AU - Hillman, M. AU - Yang, G. AU - Ellis, D. AU - Marando, C. PY - 2006 DA - 2006// TI - Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells JO - Cancer Biol Ther VL - 5 UR - https://doi.org/10.4161/cbt.5.6.2708 DO - 10.4161/cbt.5.6.2708 ID - Liu2006 ER - TY - JOUR AU - Crawford, H. C. AU - Dempsey, P. J. AU - Brown, G. AU - Adam, L. AU - Moss, M. L. PY - 2009 DA - 2009// TI - ADAM10 as a therapeutic target for cancer and inflammation JO - Curr Pharm Des VL - 15 UR - https://doi.org/10.2174/138161209788682442 DO - 10.2174/138161209788682442 ID - Crawford2009 ER - TY - JOUR AU - Codony-Servat, J. AU - Albanell, J. AU - Lopez-Talavera, J. C. AU - Arribas, J. AU - Baselga, J. PY - 1999 DA - 1999// TI - Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells JO - Cancer Res VL - 59 ID - Codony-Servat1999 ER - TY - JOUR AU - Gouyer, V. AU - Conti, M. AU - Devos, P. AU - Zerimech, F. AU - Copin, M. C. AU - Creme, E. AU - Wurtz, A. AU - Porte, H. AU - Huet, G. PY - 2005 DA - 2005// TI - Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20965 DO - 10.1002/cncr.20965 ID - Gouyer2005 ER - TY - JOUR AU - Schrohl, A. S. AU - Holten-Andersen, M. N. AU - Peters, H. A. AU - Look, M. P. AU - Meijer-van Gelder, M. E. AU - Klijn, J. G. AU - Brunner, N. AU - Foekens, J. A. PY - 2004 DA - 2004// TI - Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0360 DO - 10.1158/1078-0432.CCR-03-0360 ID - Schrohl2004 ER - TY - JOUR AU - Klintman, M. AU - Ornbjerg Wurtz, S. AU - Christensen, I. J. AU - Braemer Hertel, P. AU - Ferno, M. AU - Malmberg, M. AU - Mouridsen, H. AU - Cold, F. AU - Schrohl, A. S. AU - Foekens, J. A. PY - 2010 DA - 2010// TI - Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer JO - Breast Cancer Res Treat VL - 121 UR - https://doi.org/10.1007/s10549-009-0483-1 DO - 10.1007/s10549-009-0483-1 ID - Klintman2010 ER - TY - JOUR AU - Kuvaja, P. AU - Talvensaari-Mattila, A. AU - Turpeenniemi-Hujanen, T. PY - 2008 DA - 2008// TI - High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma JO - Int J Cancer VL - 123 UR - https://doi.org/10.1002/ijc.23531 DO - 10.1002/ijc.23531 ID - Kuvaja2008 ER - TY - JOUR AU - Talvensaari-Mattila, A. AU - Turpeenniemi-Hujanen, T. PY - 2005 DA - 2005// TI - High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma JO - Breast Cancer Res Treat VL - 89 UR - https://doi.org/10.1007/s10549-004-1006-8 DO - 10.1007/s10549-004-1006-8 ID - Talvensaari-Mattila2005 ER - TY - JOUR AU - Lin, C. H. AU - Liau, J. Y. AU - Lu, Y. S. AU - Huang, C. S. AU - Lee, W. C. AU - Kuo, K. T. AU - Shen, Y. C. AU - Kuo, S. H. AU - Lan, C. AU - Liu, J. M. PY - 2009 DA - 2009// TI - Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia JO - Cancer Epidemiol Biomarkers Prev VL - 18 UR - https://doi.org/10.1158/1055-9965.EPI-09-0096 DO - 10.1158/1055-9965.EPI-09-0096 ID - Lin2009 ER - TY - JOUR AU - McCracken, M. AU - Olsen, M. AU - Chen, M. S. AU - Jemal, A. AU - Thun, M. AU - Cokkinides, V. AU - Deapen, D. AU - Ward, E. PY - 2007 DA - 2007// TI - Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities JO - CA Cancer J Clin VL - 57 UR - https://doi.org/10.3322/canjclin.57.4.190 DO - 10.3322/canjclin.57.4.190 ID - McCracken2007 ER - TY - JOUR AU - Chen, S. T. AU - Chen, R. A. AU - Kuo, S. J. AU - Chien, Y. C. PY - 2003 DA - 2003// TI - Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan JO - Breast Cancer Res Treat VL - 77 UR - https://doi.org/10.1023/A:1021386026051 DO - 10.1023/A:1021386026051 ID - Chen2003 ER - TY - JOUR AU - Hayakawa, T. AU - Yamashita, K. AU - Ohuchi, E. AU - Shinagawa, A. PY - 1994 DA - 1994// TI - Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2) JO - J Cell Sci VL - 107 ID - Hayakawa1994 ER - TY - JOUR AU - Sugano, K. AU - Ushiama, M. AU - Fukutomi, T. AU - Tsuda, H. AU - Kitoh, T. AU - Ohkura, H. PY - 2000 DA - 2000// TI - Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse JO - Int J Cancer VL - 89 UR - https://doi.org/3.0.CO;2-P DO - 3.0.CO;2-P ID - Sugano2000 ER - TY - JOUR AU - Lipton, A. AU - Ali, S. M. AU - Leitzel, K. AU - Demers, L. AU - Evans, D. B. AU - Hamer, P. AU - Brown-Shimer, S. AU - Pierce, K. AU - Carney, W. PY - 2007 DA - 2007// TI - Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22637 DO - 10.1002/cncr.22637 ID - Lipton2007 ER - TY - JOUR AU - Cook, G. B. AU - Neaman, I. E. AU - Goldblatt, J. L. AU - Cambetas, D. R. AU - Hussain, M. AU - Luftner, D. AU - Yeung, K. K. AU - Chan, D. W. AU - Schwartz, M. K. AU - Allard, W. J. PY - 2001 DA - 2001// TI - Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer JO - Anticancer Res VL - 21 ID - Cook2001 ER - TY - JOUR AU - Kong, S. Y. AU - Nam, B. H. AU - Lee, K. S. AU - Kwon, Y. AU - Lee, E. S. AU - Seong, M. W. AU - Lee do, H. AU - Ro, J. PY - 2006 DA - 2006// TI - Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer JO - Clin Chem VL - 52 UR - https://doi.org/10.1373/clinchem.2006.067512 DO - 10.1373/clinchem.2006.067512 ID - Kong2006 ER - TY - JOUR AU - Beltran, M. AU - Colomer, R. PY - 2002 DA - 2002// TI - Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease? JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.99.191 DO - 10.1200/JCO.2002.99.191 ID - Beltran2002 ER - TY - JOUR AU - Fehm, T. AU - Gebauer, G. AU - Jager, W. PY - 2002 DA - 2002// TI - Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients JO - Breast Cancer Res Treat VL - 75 UR - https://doi.org/10.1023/A:1019601022456 DO - 10.1023/A:1019601022456 ID - Fehm2002 ER - TY - JOUR AU - Lipton, A. AU - Ali, S. M. AU - Leitzel, K. AU - Demers, L. AU - Chinchilli, V. AU - Engle, L. AU - Harvey, H. A. AU - Brady, C. AU - Nalin, C. M. AU - Dugan, M. PY - 2002 DA - 2002// TI - Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.20.6.1467 DO - 10.1200/JCO.20.6.1467 ID - Lipton2002 ER - TY - JOUR AU - Colomer, R. AU - Llombart-Cussac, A. AU - Lluch, A. AU - Barnadas, A. AU - Ojeda, B. AU - Caranana, V. AU - Fernandez, Y. AU - Garcia-Conde, J. AU - Alonso, S. AU - Montero, S. PY - 2004 DA - 2004// TI - Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh048 DO - 10.1093/annonc/mdh048 ID - Colomer2004 ER - TY - JOUR AU - Ludovini, V. AU - Gori, S. AU - Colozza, M. AU - Pistola, L. AU - Rulli, E. AU - Floriani, I. AU - Pacifico, E. AU - Tofanetti, F. R. AU - Sidoni, A. AU - Basurto, C. PY - 2008 DA - 2008// TI - Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdm585 DO - 10.1093/annonc/mdm585 ID - Ludovini2008 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Fernandez-Real, J. M. AU - Oliveras-Ferraros, C. AU - Navarrete, J. M. AU - Martin-Castillo, B. AU - Del Barco, S. AU - Brunet, J. AU - Menendez, J. A. PY - 2009 DA - 2009// TI - Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients JO - Int J Oncol VL - 35 ID - Vazquez-Martin2009 ER - TY - JOUR AU - Amour, A. AU - Knight, C. G. AU - Webster, A. AU - Slocombe, P. M. AU - Stephens, P. E. AU - Knauper, V. AU - Docherty, A. J. AU - Murphy, G. PY - 2000 DA - 2000// TI - The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3 JO - FEBS Lett VL - 473 UR - https://doi.org/10.1016/S0014-5793(00)01528-3 DO - 10.1016/S0014-5793(00)01528-3 ID - Amour2000 ER - TY - JOUR AU - Bourboulia, D. AU - Stetler-Stevenson, W. G. PY - 2010 DA - 2010// TI - Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion JO - Semin Cancer Biol VL - 20 UR - https://doi.org/10.1016/j.semcancer.2010.05.002 DO - 10.1016/j.semcancer.2010.05.002 ID - Bourboulia2010 ER - TY - JOUR AU - Stetler-Stevenson, W. G. PY - 2008 DA - 2008// TI - Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities JO - Sci Signal VL - 1 UR - https://doi.org/10.1126/scisignal.127re6 DO - 10.1126/scisignal.127re6 ID - Stetler-Stevenson2008 ER - TY - JOUR AU - Akahane, T. AU - Akahane, M. AU - Shah, A. AU - Thorgeirsson, U. P. PY - 2004 DA - 2004// TI - TIMP-1 stimulates proliferation of human aortic smooth muscle cells and Ras effector pathways JO - Biochem Biophys Res Commun VL - 324 UR - https://doi.org/10.1016/j.bbrc.2004.09.063 DO - 10.1016/j.bbrc.2004.09.063 ID - Akahane2004 ER - TY - JOUR AU - Liu, X. W. AU - Bernardo, M. M. AU - Fridman, R. AU - Kim, H. R. PY - 2003 DA - 2003// TI - Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M302999200 DO - 10.1074/jbc.M302999200 ID - Liu2003 ER - TY - JOUR AU - Liu, X. W. AU - Taube, M. E. AU - Jung, K. K. AU - Dong, Z. AU - Lee, Y. J. AU - Roshy, S. AU - Sloane, B. F. AU - Fridman, R. AU - Kim, H. R. PY - 2005 DA - 2005// TI - Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: a potential oncogenic activity of tissue inhibitor of metalloproteinase-1 JO - Cancer Res VL - 65 ID - Liu2005 ER - TY - JOUR AU - Zhang, Q. AU - Thomas, S. M. AU - Lui, V. W. AU - Xi, S. AU - Siegfried, J. M. AU - Fan, H. AU - Smithgall, T. E. AU - Mills, G. B. AU - Grandis, J. R. PY - 2006 DA - 2006// TI - Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation JO - Proc Natl Acad Sci USA VL - 103 UR - https://doi.org/10.1073/pnas.0509719103 DO - 10.1073/pnas.0509719103 ID - Zhang2006 ER - TY - JOUR AU - Wurtz, S. O. AU - Schrohl, A. S. AU - Mouridsen, H. AU - Brunner, N. PY - 2008 DA - 2008// TI - TIMP-1 as a tumor marker in breast cancer--an update JO - Acta Oncol VL - 47 UR - https://doi.org/10.1080/02841860802022976 DO - 10.1080/02841860802022976 ID - Wurtz2008 ER - TY - JOUR AU - Lipton, A. AU - Leitzel, K. AU - Chaudri-Ross, H. A. AU - Evans, D. B. AU - Ali, S. M. AU - Demers, L. AU - Hamer, P. AU - Brown-Shimer, S. AU - Pierce, K. AU - Gaur, V. AU - Carney, W. PY - 2008 DA - 2008// TI - Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.4336 DO - 10.1200/JCO.2007.15.4336 ID - Lipton2008 ER -